Lapatax: a phase I study of neoadjuvant lapatinib combined with docetaxel in Her2/neu overexpressing breast cancer (BC). EORTC protocol 10054 : poster 5112

Authors
Publication date
1 January 2008
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Serveur académique lausannois

    redirect
    oaioai:serval.unil.ch:BIB_7E2B4ED...
    Last time updated on 24/10/2013